Prokaryotics : Prokaryotics Announces Exclusive Worldwide Licensing Agreement with MEDINA for New Antibiotic Compounds
Prokaryotics, Inc. announced that it has entered into an exclusive licensing agreement with Fundación MEDINA, the not-for-profit Spanish foundation Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucia.
Read full article »
Prokaryotics is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of bacterial diseases.
Read more